Literature DB >> 28400508

ACOX2 deficiency in primary malignant cardiac tumors.

Xiangyu Zhou1,2, Hongyan Wang3,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28400508      PMCID： PMC5422777          DOI： 10.1073/pnas.1701212114

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  4 in total

1.  Identification of ACOX2 as a shared genetic risk factor for preeclampsia and cardiovascular disease.

Authors:  Asa Johansson; Joanne E Curran; Matthew P Johnson; Katy A Freed; Mona H Fenstad; Line Bjørge; Irina P Eide; Melanie A Carless; David L Rainwater; Harald H H Goring; Rigmor Austgulen; Eric K Moses; John Blangero
Journal:  Eur J Hum Genet       Date:  2011-02-23       Impact factor: 4.246

2.  ACOX2 deficiency: An inborn error of bile acid synthesis identified in an adolescent with persistent hypertransaminasemia.

Authors:  Maria J Monte; Marta Alonso-Peña; Oscar Briz; Elisa Herraez; Carmen Berasain; Josepmaria Argemi; Jesus Prieto; Jose J G Marin
Journal:  J Hepatol       Date:  2016-11-21       Impact factor: 25.083

3.  ACOX2 deficiency: A disorder of bile acid synthesis with transaminase elevation, liver fibrosis, ataxia, and cognitive impairment.

Authors:  Sílvia Vilarinho; Sinan Sari; Francesca Mazzacuva; Kaya Bilgüvar; Güldal Esendagli-Yilmaz; Dhanpat Jain; Gülen Akyol; Buket Dalgiç; Murat Günel; Peter T Clayton; Richard P Lifton
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-19       Impact factor: 11.205

4.  Expression of an estrogen-regulated variant transcript of the peroxisomal branched chain fatty acid oxidase ACOX2 in breast carcinomas.

Authors:  Sunniva Stordal Bjørklund; Vessela N Kristensen; Michael Seiler; Surendra Kumar; Grethe I Grenaker Alnæs; Yao Ming; John Kerrigan; Bjørn Naume; Ravi Sachidanandam; Gyan Bhanot; Anne-Lise Børresen-Dale; Shridar Ganesan
Journal:  BMC Cancer       Date:  2015-07-17       Impact factor: 4.430
  4 in total
  4 in total

1.  Combined effects of FH (E404D) and ACOX2 (R409H) cause metabolic defects in primary cardiac malignant tumor.

Authors:  Xiangyu Zhou; Mengjia Xu; Weijia Zeng; Zhongzhong Chen; Guohui Lu; Yun Gong; Richard H Finnell; Huasheng Xiao; Bin Qiao; Hongyan Wang
Journal:  Cell Death Discov       Date:  2018-07-23

2.  ACOX2 is a prognostic marker and impedes the progression of hepatocellular carcinoma via PPARα pathway.

Authors:  Qifan Zhang; Yunbin Zhang; Shibo Sun; Kai Wang; Jianping Qian; Zhonglin Cui; Tao Tao; Jie Zhou
Journal:  Cell Death Dis       Date:  2021-01-04       Impact factor: 8.469

3.  Acox2 is a regulator of lysine crotonylation that mediates hepatic metabolic homeostasis in mice.

Authors:  Yuan Zhang; Yuling Chen; Zhao Zhang; Xiang Tao; Sha Xu; Xinyan Zhang; Tinatin Zurashvili; Zhouping Lu; José Ramon Bayascas; Liping Jin; Jianyuan Zhao; Xiangyu Zhou
Journal:  Cell Death Dis       Date:  2022-03-29       Impact factor: 9.685

4.  Altered expression of ACOX2 in non-small cell lung cancer.

Authors:  Jane S Y Sui; Petra Martin; Anna Keogh; Pierre Murchan; Lisa Ryan; Siobhan Nicholson; Sinead Cuffe; Pilib Ó Broin; Stephen P Finn; Gerard J Fitzmaurice; Ronan Ryan; Vincent Young; Steven G Gray
Journal:  BMC Pulm Med       Date:  2022-08-23       Impact factor: 3.320
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.